Accessibility Menu
 
Tandem Diabetes Care logo

Tandem Diabetes Care

(NASDAQ) TNDM

Current Price$19.49
Market Cap$1.33B
Since IPO (2013)-90%
5 Year-79%
1 Year-3%
1 Month+3%

Tandem Diabetes Care Financials at a Glance

Market Cap

$1.33B

Revenue (TTM)

$1.01B

Net Income (TTM)

$204.71M

EPS (TTM)

$-3.07

P/E Ratio

-6.33

Dividend

$0.00

Beta (Volatility)

1.42 (Average)

Price

$19.49

Volume

41,270

Open

$19.79

Previous Close

$19.49

Daily Range

$19.19 - $20.00

52-Week Range

$9.98 - $29.65

TNDM: Motley Fool Moneyball Superscore

62

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Tandem Diabetes Care

Industry

Healthcare Equipment and Supplies

Employees

2,500

CEO

John F. Sheridan, MBA

Headquarters

San Diego, CA 92121, US

TNDM Financials

Key Financial Metrics (TTM)

Gross Margin

54%

Operating Margin

-18%

Net Income Margin

-20%

Return on Equity

-98%

Return on Capital

-29%

Return on Assets

-23%

Earnings Yield

-15.80%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.33B

Shares Outstanding

68.50M

Volume

41.27K

Avg. Volume

2.07M

Financials (TTM)

Gross Profit

$530.85M

Operating Income

$78.12M

EBITDA

$174.70M

Operating Cash Flow

$9.72M

Capital Expenditure

$19.95M

Free Cash Flow

$29.67M

Cash & ST Invst.

$292.67M

Total Debt

$444.48M

Tandem Diabetes Care Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$290.38M

+2.7%

Gross Profit

$167.46M

+6.4%

Gross Margin

57.67%

N/A

Market Cap

$1.33B

N/A

Market Cap/Employee

$502.02K

N/A

Employees

2,650

N/A

Net Income

$589.00K

-178.0%

EBITDA

$11.25M

+83.8%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$271.68M

-671.0%

Accounts Receivable

$165.49M

+44.4%

Inventory

$128.77M

-13.9%

Long Term Debt

$539.97M

+30.2%

Short Term Debt

$24.37M

-58.6%

Return on Assets

-23.23%

N/A

Return on Invested Capital

-28.89%

N/A

Free Cash Flow

$3.10M

-59.4%

Operating Cash Flow

$9.79M

-8.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NRIXNurix Therapeutics, Inc.
$16.81+0.66%
FTREFortrea Holdings Inc.
$12.18+5.91%
URGNUroGen Pharma Ltd.
$23.00-3.48%
EYPTEyePoint Pharmaceuticals, Inc.
$13.34+1.06%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$13.30+0.03%
NVDANvidia
$198.45-0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%

Questions About TNDM

What is the current price of Tandem Diabetes Care?

Tandem Diabetes Care is trading at $19.49 per share.

What is the 52-week range for Tandem Diabetes Care?

Over the past 52 weeks, Tandem Diabetes Care has traded between $9.98 and $29.65.

How much debt does Tandem Diabetes Care have?

As of the most recent reporting period, Tandem Diabetes Care reported total debt of $449.38M.

How much cash does Tandem Diabetes Care have on hand?

Tandem Diabetes Care reported $90.63M in cash and cash equivalents in its most recent financial results.

What is Tandem Diabetes Care’s dividend yield?

Tandem Diabetes Care does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.